NCT01260857View on ClinicalTrials.gov

Safety And Efficacy Of Spirinolactone Plus Hydroflumethiazide In The Treatment Of Filipino Patients With Hypertension

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

March 31, 2013

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions
Hypertension
Interventions
DRUG

Aldazide

Aldazide 25 mg OD

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT01260857 - Safety And Efficacy Of Spirinolactone Plus Hydroflumethiazide In The Treatment Of Filipino Patients With Hypertension | Biotech Hunter | Biotech Hunter